ORCHID PHARMA
Back to Balance Sheet
|
ORCHID PHARMA Last 5 Year Total Debt History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Debt | ₹174 Cr | ₹134 Cr | ₹331 Cr | ₹268 Cr | ₹453 Cr |
What is the latest Total Debt ratio of ORCHID PHARMA ?
| Year | Total Debt |
|---|---|
| Mar2025 | ₹174 Cr |
| Mar2024 | ₹134 Cr |
| Mar2023 | ₹331 Cr |
| Mar2022 | ₹268 Cr |
| Mar2021 | ₹453 Cr |
How is Total Debt of ORCHID PHARMA Trending?
| Years | Total Debt | % Change | |
|---|---|---|---|
| Mar2025 | ₹174 Cr | 29.57 | |
| Mar2024 | ₹134 Cr | -59.41 | |
| Mar2023 | ₹331 Cr | 23.66 | |
| Mar2022 | ₹268 Cr | -40.82 | |
| Mar2021 | ₹453 Cr | - | |
Compare Total Debt of peers of ORCHID PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ORCHID PHARMA | ₹2,762.9 Cr | 4.8% | 6.8% | -26.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹396,370.0 Cr | -3.9% | -8.9% | -3.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹161,193.0 Cr | 3.8% | -4.7% | 11.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹141,438.0 Cr | 3.2% | -5.6% | 26.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,097.0 Cr | 3.3% | -6% | 11% | Stock Analytics | |
| CIPLA | ₹97,846.7 Cr | 0.8% | -9.1% | -13.1% | Stock Analytics | |
ORCHID PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ORCHID PHARMA | 4.8% |
6.8% |
-26.2% |
| SENSEX | 3.7% |
-0.9% |
0.7% |
You may also like the below Video Courses